Drug profile · INN
pegunigalsidase alfa-iwxj
ELFABRIO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pegunigalsidase alfa-iwxj (ELFABRIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: single-use. Current US regulatory status: approved.
Key facts
INN pegunigalsidase alfa-iwxj
Brand ELFABRIO
Route SINGLE-USE
Formulation VIAL
Frequently asked questions
What is pegunigalsidase alfa-iwxj?
pegunigalsidase alfa-iwxj (ELFABRIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: single-use. Current US regulatory status: approved.
What is the brand name for pegunigalsidase alfa-iwxj?
ELFABRIO is a marketed brand name for pegunigalsidase alfa-iwxj. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegunigalsidase alfa-iwxj?
pegunigalsidase alfa-iwxj has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.